[Methodological bases for an approach to the use of screening tests in the biochemical diagnosis of malignant neoplasms].
D000324:Adrenocorticotropic Hormone / Q000032:analysis; D002272:Carcinoembryonic Antigen / Q000032:analysis; D006063:Chorionic Gonadotropin / Q000097:blood; D004798:Enzymes / Q000097:blood; D005260:Female; D006729:Hormones, Ectopic / Q000032:analysis; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D009369:Neoplasms / Q000097:blood / Q000517:prevention & control*; D011073:Polyamines / Q000097:blood; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D000509:alpha-Fetoproteins / Q000032:analysis
D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D004798:Enzymes; D006729:Hormones, Ectopic; D011073:Polyamines; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D000509:alpha-Fetoproteins; D000324:Adrenocorticotropic Hormone
Metodologicheskie osnovy podkhoda k ispol'zovaniiu skriningov v biokhimicheskoĭ diagnostike zlokachestvennykh novoobrazovaniĭ.